Page last updated: 2024-08-21

evans blue and Neoplasms, Pleural

evans blue has been researched along with Neoplasms, Pleural in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cottin, T; Giannis, A; Kalomenidis, I; Kollintza, A; Moschos, C; Papiris, S; Psallidas, I; Roussos, C; Stathopoulos, GT	1

Other Studies

1 other study(ies) available for evans blue and Neoplasms, Pleural

Article	Year
A sulindac analogue is effective against malignant pleural effusion in mice. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 73, Issue:2 Topics: Animals; Capillary Permeability; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytokines; Evans Blue; Inflammation Mediators; Mice; Mice, Inbred C57BL; Pleural Effusion, Malignant; Pleural Neoplasms; Sulindac; Tumor Burden; Xenograft Model Antitumor Assays	2011

Article

Year

A sulindac analogue is effective against malignant pleural effusion in mice.

Lung cancer (Amsterdam, Netherlands), 2011, Volume: 73, Issue:2

Topics: Animals; Capillary Permeability; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytokines; Evans Blue; Inflammation Mediators; Mice; Mice, Inbred C57BL; Pleural Effusion, Malignant; Pleural Neoplasms; Sulindac; Tumor Burden; Xenograft Model Antitumor Assays

2011